TRBCX (TRBCX) Stock Price & Analysis
TRBCX (TRBCX) fell 0.61% to USD 211.79 as of June 10, 2026 at 12:24 UTC, according to Nexqual real-time market data.
TRBCX last closed at USD 213.1; the session ranged USD 211.79–211.79 on volume of 0 shares. Market capitalization is —, with a 52-week range of USD 179.68–227.75 (NAS). Source: Nexqual, June 10, 2026 at 12:24 UTC.
Key Statistics (as of June 10, 2026 at 12:24 UTC)
| Price | USD 211.79 |
|---|---|
| Change | ▼ 0.61% (down) |
| Previous Close | USD 213.1 |
| Open | USD 211.79 |
| Day Range | USD 211.79 – 211.79 |
| 52-Week Range | USD 179.68 – 227.75 |
| Volume | 0 shares |
| Market Cap | — |
| Exchange | NAS |
Technical Analysis (TRBCX)
Nexqual's technical model rates TRBCX "BUY" based on 4 bullish and 2 bearish signals across 123 daily candles, as of June 10, 2026 at 12:24 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 43.96 (neutral) |
| vs SMA50 | Above (USD 209.27) |
| MACD | 1.69 (positive) |
Financial Health Score (TRBCX)
Nexqual rates TRBCX's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 12:24 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| RPMGX | T. Rowe Price Mid-Cap Growth Fu | USD 98.74 | ▲ 0.96% |
| PRHSX | T. Rowe Price Health Sciences F | USD 82.82 | ▲ 1.4% |
| PRFDX | T. Rowe Price Equity Income Fd | USD 43.05 | ▲ 0.63% |
| PRSCX | T. Rowe Price Science and Techn | USD 73.91 | ▲ 1.36% |
| PRNHX | T. Rowe Price New Horizons Fund | USD 56.98 | ▲ 1.15% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 12:24 UTC. This page is informational and not investment advice.